News

Vical has received US Patent No. 7537768, covering the use of influenza virus gene sequences in a universal vaccine that could provide protection against circulating seasonal strains as

Novartis has announced that the investigational biological therapy Ilaris produced rapid and sustained remission of symptoms in patients with a rare and potentially life-threatening auto-inflammatory disease, cryopyrin-associated periodic

Johnson & Johnson has announced the results of ongoing phase 2, randomized, placebo-controlled trial of the investigational drug TMC207. The drug will be used for the treatment of

Net sales attributable to the epilepsy indication of $140 million compared to $115.3 million in fiscal year 2008, a 21% increase; Gross margin of 86.0%, compared with 82.6%

Cegedim Dendrite has announced a 3 year agreement with Sanofi Aventis to provide Mobile Intelligence CRM solution to over 20,000 users across 28 countries including US, France and

The agreement ensures that the hospital is equipped with solutions that put clinicians’ and patients’ needs at the centre of care. Medical equipment will be replaced in line

AOE or “swimmer’s ear” is a common childhood infection of the ear canal characterised by intense pain and inflamed, damaged skin. AOE treatment should address three main goals

syngo Suite, Siemens web-enabled radiology information system (RIS) and picture archiving and communications system (PACS) with post-processing applications, computer-aided detection (CAD) applications, and embedded speech recognition, consists of

Marc Oczachowski, EDAP’s chief executive officer, stated that the company strongly believes Jorge Litter in Argentina, H. Strattner in Brazil and UMS in Chile are the right partners